Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $5.3 million.

  • Veracyte's Depreciation & Amortization (CF) fell 1041.17% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 497.83%. This contributed to the annual value of $23.5 million for FY2024, which is 1371.56% down from last year.
  • According to the latest figures from Q3 2025, Veracyte's Depreciation & Amortization (CF) is $5.3 million, which was down 1041.17% from $5.5 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Depreciation & Amortization (CF) registered a high of $7.3 million during Q3 2023, and its lowest value of $2.6 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $6.3 million (2024), whereas its average is $5.9 million.
  • In the last 5 years, Veracyte's Depreciation & Amortization (CF) skyrocketed by 21624.69% in 2021 and then plummeted by 1973.24% in 2024.
  • Over the past 5 years, Veracyte's Depreciation & Amortization (CF) (Quarter) stood at $6.4 million in 2021, then increased by 2.37% to $6.6 million in 2022, then decreased by 3.36% to $6.3 million in 2023, then decreased by 1.31% to $6.3 million in 2024, then dropped by 15.78% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $5.5 million for Q2 2025, and $5.4 million during Q1 2025.